Connection

Mark Hamner to Combined Modality Therapy

Back to Details
This is a "connection" page, showing publications Mark Hamner has written about Combined Modality Therapy.
Mark Hamner
Connection Strength
0.285
Combined Modality Therapy
  1. Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn Behav Ther. 2018 09; 47(5):351-371.
    View in: PubMed
    Score: 0.122
  2. Treatment-resistant posttraumatic stress disorder: strategies for intervention. CNS Spectr. 2004 Oct; 9(10):740-52.
    View in: PubMed
    Score: 0.048
  3. Cortisol awakening response in PTSD treatment: Predictor or mechanism of change. Psychoneuroendocrinology. 2020 08; 118:104714.
    View in: PubMed
    Score: 0.036
  4. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
    View in: PubMed
    Score: 0.028
  5. Discontinuation of antidepressant medications before ECT. Convuls Ther. 1996 Jun; 12(2):125-6.
    View in: PubMed
    Score: 0.027
  6. Exacerbation of posttraumatic stress disorder symptoms with medical illness. Gen Hosp Psychiatry. 1994 Mar; 16(2):135-7.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.